Biotricity (BTCY) Expected to Post Earnings on Friday

Biotricity (NASDAQ:BTCY) will likely be announcing its Q4 2026 resultson Friday, June 26th. Analysts expect Biotricity to post earnings of ($0.08) per share and revenue of $4.10 million for the quarter. Parties can check the company’s upcoming Q4 2026 earning overview page for the latest details on the call scheduled for Friday, June 26, 2026 at 4:00 PM ET.

Biotricity Stock Performance

Shares of BTCY stock opened at $0.12 on Friday. The stock’s fifty day moving average price is $0.19 and its two-hundred day moving average price is $0.26. The company has a market cap of $3.45 million, a PE ratio of -0.11 and a beta of 1.15. Biotricity has a fifty-two week low of $0.10 and a fifty-two week high of $0.75.

About Biotricity

Biotricity, Inc (NASDAQ:BTCY) is a digital health company specializing in remote patient monitoring solutions across cardiovascular and chronic disease management. The firm develops and commercializes a patented wearable biosensor platform designed to capture continuous physiological data, including electrocardiogram (ECG) readings and heart rate variability. This integrated system combines lightweight, adhesive biosensors with cloud-based analytics and clinician-facing software to support early detection of cardiac arrhythmias and facilitate telehealth care delivery.

The company’s flagship offering, the Bioflux™ platform, comprises a small, single-use wearable device that transmits real-time data to a secure portal, where advanced algorithms analyze cardiac patterns and generate clinician alerts.